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Abstract.  We have used a variety of immunocyto- 
chemical procedures to localize albumin in transit 
through the capillary endothdium of the murine myo- 
cardium and thereby identify endothelial cell struc- 
tures involved in albumin efflux. The most informative 
results were obtained with a protocol that included (a) 
removal of endogenous albumin by perfusion of the 
heart with PBS supplemented with 14 mM glucose, 
(b) perfusion of the heart vasculature with exogenous 
(bovine) albumin for various short time periods, (c) 
fixation of the vessels by formaldehyde-glutaraldehyde 
mixtures, (d) processing of fixed myocardium speci- 
mens through L. R. White embedding followed by 
sectioning, or direct thin frozen sectioning, and (e) 
reacting the surface of such specimens with antialbu- 
min antibodies followed by gold-labeled secondary 
antibodies. The results indicate that (a) monomeric al- 
bumin binds (with low affinity) to the luminal surface 
of the capillary endothelium, (b) it is restricted in 
transit through the endothelium to plasmalemmal vesi- 
cles, and (c) it appears in the pericapillary spaces <15 
s after the beginning of its perfusion. No albumin con- 
centration gradients, centered with their maxima on 
the exits from intercellular spaces, were detected at 
any time points, including the shortest ones (15 and 
30 s) investigated. Additional information comparing 
monomeric vs. polymeric albumin transcytosis was ob- 
tained using albumin-gold complexes. The results are 
discussed in terms of vesicular transport of albumin 
across the endothelium and the relations of this type 
of transport to the postulated pore systems of the phys- 
iological literature. 
W 
P'ITHIN the cardiovascular system, albumin performs 
a variety of functions,  including (a) maintenance 
of  the oncotic pressure of  the blood plasma (13), (b) 
regulation of the permeability of the microvasculature  by 
forming a "fiber matrix" through interaction with the ectodo- 
mains of the proteins of the luminal plasmalemma of the en- 
dothelium and its associated structures (6), and (c) transport 
of fatty acids,  steroids,  hormones, and bilirubin  within the 
circulation and between the plasma and interstitial fluid (2, 
5, 27). In part, the carrier functions of albumin involve its 
own transport across the vascular endothelium, primarily at 
the level of  the microvasculature as evidenced  by its presence 
in varied but characteristic concentrations within the intersti- 
tial fluid and lymph associated  with, or derived from, all 
microvascular beds. 
At present, the pathways, forces, and mechanisms involved 
in albumin transport from the blood plasma to the interstitial 
fluid are issues on which there is no general agreement. Data 
obtained in physiological experiments have been interpreted 
in  terms of albumin  moving  by diffusion  and convection 
through a system of small (~<12 nm diam) and large (20-50 
nm diam) pores (10, 15, 20) widely assumed to be located in 
the intercellular  junctions of the endothelium (13, 20). Move- 
ment through these pores is presumably regulated by the 
fibrous matrix and controlled by concentration gradients and 
pressure differentials. 
The role of the plasmalemmal vesicles of the endothelial 
cells in the transport of albumin and other solutes is still un- 
der debate. Although attempts to visualize directly the path- 
way followed by albumin from the blood plasma to the inter- 
stitial  fluid  have  implicated  primarily these vesicles,  the 
results cannot be considered definitive. For instance,  with 
horseradish  peroxidase  (HRP)-labeled  1 antibodies,  plasma 
proteins  (including  albumin)  were localized primarily to 
plasmalemmal vesicles. The findings were taken to indicate 
vesicular transport of albumin (23, 30), but other pathways 
were not convincingly  ruled out because of the excessive 
amounts  and extensive spreading  of the reaction products 
generated in the pericapillary spaces by the technique used. 
Albumin-gold  (AuBSA) complexes  were  localized  with 
remarkable specificity to the plasmalemmal vesicles of  capil- 
lary endothelia by Ghitescu et al. (8). Binding was shown to 
be saturable  and competible by monomeric albumin, but 
transport across the endothelium was found to be unexpect- 
edly slow. AuBSA complexes  have large dimensions and 
probably behave like polymerized albumin,  which may in- 
fluence  binding, dissociation, and even rates and pathways of 
transport. 
In this paper we describe experiments in which we have 
used monomeric albumin as tracer and gold-tagged antibod- 
ies as detector. The results obtained indicate that, in murine 
myocardial capillaries,  albumin is rapidly transported to the 
pericapillary spaces (exit time, <15 s) apparently exclusively 
through plasmalemmal vesicles. 
1, A/~rev/at/ons  usedin th/spaper:. AuBSA, albumin-gold; HRP, horserad- 
ish peroxidase; PBSG, PBS supplemented with 14 mM glucose; PBSO, PBS 
containing 1% ovalbumin. 
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Animals 
Male Swiss albino mice (Charles River Breeding Laboratories, Inc., Wil- 
mington, MA) weighing 20-25 g were used in all experiments.  All animals 
were allowed free access to food and water. 
Materials 
Reagents and other supplies were obtained as indicated below:  PBS from 
Gibeo, Grand Island, NY; BSA fraction V, ovalbumin grade V, polyvinyl- 
pyrrolidone (Mr 10,000), polyvinyl alcohol  (Mr 10,000), paraformaldehyde 
and 3-3' diaminobenzidine from Sigma Chemical Co.,  St.  Louis,  MO; 
glutaraldehyde  from Electron Microscopy  Sciences,  Fort Washington,  PA; 
L. R. White resin, medium grade,  from Ernest E  Fullam, Inc., Latham, 
NY; HRP goat anti-rabbit  IgG, tannic acid, and BEEM capsules from Poly- 
se'mnces Inc., Warrington,  PA; rabbit anti-BSA from CooperBiomedical, 
Inc., Malvern, PA; goat anti-rabbit IgG-Au~ (GAR~) from Janssen Life 
Sciences Products,  Piscataway, NJ; sodium sulfite and polyethylene glycol 
(Mr 20,000)- from J. T. Baker Products,  Phillipsburg, NY. 
Experimental Protocol 
Under light ether anesthesia, a thoracotomy  was performed and a carmula, 
connected to a constant pressure perfusion apparatus,  was inserted into the 
left ventricle. The right atrium was cut open to allow drainage during the 
rest of the procedure. The blood was then removed by perfusing the animal 
with 30-40 ml of PBS supplemented with 14 mM glucose (PBSG). The 
PBSG and all other solutions were warmed up to 37~  and oxygenated be- 
fore use. The perfusion was carded out at a rate of 3.5 ml/min and at a pres- 
sure of 90 mmHg. Preliminary tests showed that this was sufficient to re- 
move endogenous albumin from the microvasculamre  as well as from most 
of the pericapiUary  spaces. The vasculature  was first perfused with PBSG 
containing 30 mg/ml BSA for 15 s, 30 s,  1 min, 2 rain, 4 win, or 5 min 
(this step was omitted in the control experiments), and then with a mixture 
of 4%  formaldehyde-0.5%  glutaraldebyde  in 0.1  M  Na cacodylate-HCl 
buffer, pH 7,4. In some experiments this fixation step was preceded by a 
1-min flush with PBSG. The myocardium was then removed, cut into small 
blocks which were immersed in the same fixative for up to 18 h. The blocks 
were then washed in 0.2 M Na cacodylate-HCl  buffer, pH 7.4, (2 ￿  10 rain) 
and processed as described below. 
Immunogold Procedure 
L. R.  White-embedded Specimens. The washed tissue blocks were de- 
hydrated through a series of graded ethanol solutions (70, 80, and 95%) 
starting at 4~  and immediately going to -20~  They were subsequently 
infiltrated  in a 70/30 mixture of L. R. White resin and 95 % ethanol (1 h 
at -20~  and then left overnight in 100% L. R. White resin (-20~  The 
next day the blocks were transferred to fresh resin in BEEM capsules  and 
the resin was allowed to polymerize at -20~  Silver-to-gray thin sections 
were  cut on an Ultracut E  microtome (Reichert  Scientific  Instruments, 
Buffalo, NY) and were picked up on nickel grids. Sections  on grids were 
then floated (sectionside down) on the following solutions: (a) PBS contain- 
ing 1% ovalbumin (PBSO),  1 x  15 min; (b) rabbit anti-BSA, diluted 1:5002 
in PBSO, 1 x  90 min; (c) PBSO washes, 6  x  10 rain; (d) goat anti-rabbit 
IgG-Aus, diluted 1:500 in PBSO,  I  x  90 rain; (e) PBSO washes,  6  x  10 
rain; (f) 2% OsO4 in 0.1 M Na cacodylate-HC1  buffer, pH 7.4,  1  x  15 
min; (g) deionized distilled water washes,  3  ￿  2 min; (h) 1% tannic acid 
in 0.1 M Na cacodylate-HCl buffer, pH 6.5,  1  x  3 rain; (i) 1% sodium 
sulfite in the same buffer, 1 ￿  1 rain; (j) deionized distilled water washes, 
3  x  1 rain. Finally, the sections were lightly stained with lead citrate, and 
examined and micrographed in a Phillips 301 electron microscope. 
Thin Frozen Sectioned Specimens. Washed tissue Mocks  were pro- 
cessed according to the method of Tokuyasu (28, 29, and personal com- 
munication), which requires tissue infiltration  for 1-2 h with 50% poly- 
vinylpyrrolidone containing 2.3 M sucrose in 0.1 M phosphate buffer, pH 
7.4, followed by mounting on metal nails and freezing  in liquid nitrogen. 
Thin frozen  sections were  cut on glass knives with an ultramicrotome 
provided  with a FC-4 Cryo attachment (Reichert Scientific Instruments). 
2. Standard ELISA_s were carded out on the rabbit anti-BSA to find out to 
what extent it binds to murine albumin. The results indicate that there is 
limited cross-reactivity:  the maximum dilutions for antigen recognition 
were 1:2,000 and 1:250 for bovine and murine albumin, respectively. 
They were picked up on a drop of 1.92 M sucrose containing 0.75% gelatin 
in 9 mM phosphate buffer, pH 7.4, and placed on nickel grids. Sections on 
grids were then processed as follows: steps a tofas in the previous section, 
except that each washing step was reduced to 30 s; (g) 2% ghitaraldehyde 
in PBS,  1 x  5 min; (h) PBS wash,  1 x  1 rain; (i) 2% OsO4 in deionized 
distilled water, 1 x  15 rain; (j) deionized distilled water washes, 2 ￿  1 rain; 
(k) 0.5%  uranyl acetate in veronal acetate buffer, pH 6.0, 1 ￿  15 min; (l) 
2.5% polyvinyl alcohol containing 0.0015% lead citrate,  2 ￿  2.5 min~ The 
grids were air dried after removing  excess fluid. 
AuBSA Investigations. 7-nm gold particles  were produced  by a tannic 
acid-sodium citrate reduction of a chloroauric acid solution (17). Preliminary 
experiments showed that stable complexes  could be obtained by mixing 
equal volumes of a gold particle suspension and a 3 mg/ml BSA solution 
followed by vortexing for several minutes and by adding polyethylene glycol 
to a  final concentration of 0.01%. Excess  albumin was then removed  by 
pelleting the AuBSA particles at 150000 g~ for 45 min followed by resus- 
pension in PBS and repelleting.  The final pellet was resuspended in a mini- 
mal amount of PBS and used immediately. 
The experimental protocol  using the AuBSA particles was essentially 
identical to that using the free albumin except that the AuBSA was perfused 
for up to 17 rain, unbound AuBSA was removed with a 2-rnin PBSG flush, 
and animals were  fixed by perfusion with 3%  glntaraldehyde  in 0.1  M 
Na-cacodylate-HCl  buffer, pH 7.4. Myocardium tissue specimens were then 
processed,  embedded, and sectioned for electron microscopy  according to 
procedures previously  described (16). 
lmmunoperoxidase Localization of BSA.  AuBSA particles were pre- 
pared and perfused as described above except that the fixative  in these 
experiments was  4%  formaldehyde-0.5%  glutaraldehyde  in 0.1  M  Na- 
cacodylate-HCI  buffer, pH 7.4. After fixation,  tissue blocks were cut into 
20-11m-thick sections using an Oxford  vibratome and the sections  were 
processed through the following steps:  (a) PBSO,  1 x  30 rain; (b) rabbit 
anti-BSA, diluted 1:200 in PBSO, 1 ￿  2 h; (c) PBSO washes, 6  x  10 rain; 
(d) HRP-goat anti-rabbit IgG, diluted 1:200 in PBSO,  1 ￿  2 h, and (e) 
PBSO washes,  6  x  10 rain. The sections were then reacted  for 20 rain 
(22~  in a modified Graham-Karnovsky  incubation medium (9) that con- 
tained 1 mg/ml diaminobenzidine and 0.01% H202 (final concentration) in 
0.1 M monobasic phosphate. After incubation, the sections were routinely 
processed for electron microscopy. Controls included omission of primary 
or secondary antibody and incomplete peroxidase  reaction media. 
Morphometry. To determine the percentage of labeled vesicles, we exam- 
ined 10 random low magnification (18,000X) micrographs of L. R. White- 
embedded capillaries reacted as described above for each condition (con- 
trois, 15 s BSA perfusion and 1 min BSA perfusion) and counted in each 
case a minimum of 1,000 vesicles. 
To determine if there was a gradient of albumin in the extravascular space 
in association with endothelial cell junctions, we examined  10 micrographs 
of cross-sectioned ultrathin frozen capillaries after either 30 or 15 s BSA 
perfusion. We selected narrow (,'~0.3 ~tm) pericapillary spaces on the as- 
sumption that this would increase the chances of detecting albumin gra- 
dients, if  present, and excised therefrom samples that included the capillary 
basal lamina and the entire width of the pericapillary spaces. Two types of 
samples were collected from each micrograph: (a) 0.4 ~tm in length subtend- 
ing an intercellular junction; (b) 0.5 ~m in length located on each side of 
a. The number of gold particles in each sample ~  counted, the excised 
micrograph pieces were weighed,  and particle counts were standardized  to 
I lma  2 by dividing the total weight of each sample by the weight of a l-I~m  2 
photographic paper standard. 
Results 
AuBSA Complexes 
At all time points examined, AuBSA particles were found 
preferentially associated with luminal plasmalemmal vesi- 
cles. There was no extensive labeling of the luminal surface 
of the endotheliurn (Fig. 1 A) and occasional particles were 
seen in the infundibula leading to intercellular junctions but 
not within the junctions themselves. AuBSA particles were 
frequently found in slight depressions in the luminal plas- 
malemma, or dimples, as described by Ghitescu et al. (8). 
The particles were not removed from luminal plasmalemmal 
vesicles by flushing for several minutes with a protein-free 
The Journal of Cell Biology, Volume 105, 1987  2604 Figure 1. Myocardial capillaries perfused with AuBSA.  (.4) After a  16-min perfusion the plasmalemmal vesicles on the luminal front are 
preferentially marked by AuBSA (long arrows). The plasmalemma proper was sparsely labeled (arrowheads). Transport of tracer across 
the endothelium is limited and abluminal vesicles are only rarely labeled (short arrow). AuBSA particles are occasionally found in the 
luminal introit of intercellular junctions, but are not detected within or beyond these junctions. Bar, 0.2 Ixm. (B) Limited field in the en- 
dothelium of a capillary perfused as above to illustrate a large vacuole (V) (presumably an endosome) containing AuBSA. Note the close 
association of the tracer with the vacuolar membrane. L, lumen; PC, pericapillary spaces; E, endothelium; J, intercellular junction.  Bar, 
0.2  lam. 
perfusate and did not appear to be transported rapidly or in 
large numbers to the extravascular  space.  AuBSA particles 
were infrequently seen in plasmalemmal vesicles associated 
with the abluminal  front of the endothelium  or in the peri- 
capillary spaces. AuBSA particles were found in some coated 
vesicles/coated pits as well as in some large vacuoles pre- 
sumed to be endosomes  (Fig.  1 B). 
Immunoperoxidase tests for albumin in AuBSA perfused 
capillaries colocalized HRP reaction product with gold par- 
ticles  in  plasmalemmal  vesicles  on  both  the  luminal  and 
abluminal  surface of the endothelium,  thereby demonstrat- 
ing that BSA remained on gold particles throughout the dura- 
tion of the experiments (Fig. 2 A), Hence, the slow transcyto- 
sis rate observed can not be attributed to a loss of the albumin 
coating from the gold particles. AuBSA-labeled vesicles, ap- 
parently detached from both the luminal and abluminal en- 
dothelial  plasmalemma,  were occasionally  found and their 
AuBSA  particles  had  no  detectable  peroxidatic  reaction 
product on their surface (Fig. 2 B). Unlabeled gold particles 
were also found  in larger,  apparently  closed  vesicular ele- 
ments  assumed  to  represent  endosomes  (Fig.  2  C).  The 
peroxidatic reaction product allowed us to determine the ap- 
Figure 2. Immunoperoxidase localization of BSA in capillaries perfused with AuBSA.  After a  12-min perfusion, treatment of the tissue 
with an anti-albumin antibody followed by an HRP-coupled secondary antibody demonstrates that albumin is still present on the gold parti- 
cles. In the insert (the boxed area enlarged two times), the HRP reaction product reveals the approximate size of the albumin coat, in both 
negative (long arrow) or positive images (short arrow). The HRP reaction product to the albumin on the AuBSA marks a fraction of the 
total plasmalemmal vesicle population which includes vesicles opening on the abluminal front (arrowheads). Bar, 0.2 Ixm. (B and C) Same 
type of specimens as in A to indicate that the anti-albumin has no access to either a large coated vesicle (CV) or a large vacuole (V) (endo- 
some?) presumably because these structures are not open to either endothelial cell surface. Note that in this experiment the flushing of 
the capillary lumina (and pericapillary spaces) was not as thorough as in Fig.  1. Bar, 0.2  I~m. 
Milici et al. Endothelial Transport of Albumin  2605 Figure 3. Immunogold localization of monomeric albumin in the endothelium and pericapillary spaces of myocardial capillaries  in L. R. 
White-embedded specimens.  (.4) Control for the immunogold localization of BSA to show that a  10-rain flush with PBSG removes most 
of the detectable  albumin from the lumen, endothelium, and pericapillary spaces.  The low background (gold particles marked by arrow- 
heads) represents  either nonspecific gold anti-albumin binding or binding to endogenous albumin not fully removed by flushing. Note the 
characteristic  appearance of the intercellular  junction (J) in this L. R. White-embedded specimen: extended collapse of the intercellular 
space and extended backing of the junction by fibrillar  cytoplasmic condensations.  Bar, 0.2 I~m. (B) Specimen perfused with albumin  for 
1 rain followed by 1-min flush with PBSG. The micrograph shows labeling of  plasmalemmal vesicles (long arrows) and pericapillary spaces 
with no labeling  (in this field) of the luminal  plasmalemma and adluminal  plasmalemmal vesicles.  We assume that labeling  was removed 
from these sites by the l-rain flush that followed albumin perfusion. Bar, 0.2 era. M, myocardium. (C) After 1 rain albumin perfusion 
without a subsequent  flush, albumin is detected  on the luminal plasmalemma and in plasmalemmal  vesicles throughout the endothelium 
with heavier labeling  in adluminal  vesicles (long arrows). Albumin is also detected  apparently randomly distributed  in the pericapillary 
spaces.  Bar, 0.2 I~m. 
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stained. The average size of the complex was found to be 
,'-,14.5 nm and that of the gold particles alone, •7  nm. 
Immunogoid Localization of  Exogenous, 
Monomeric Albumin 
LR White Sections. In specimens embedded in L. R. White 
resin,  albumin antigenicity is retained,  but the structural 
preservation of the microvessels is suboptimal. Endothelial 
cells are generally intact, but the components of their cyto- 
plasmic matrix are often coarsely precipitated. Moreover, 
cellular membranes are not clearly defined and occasionally 
show small-scale (<2-3 nm) discontinuities. Plasmalemmal 
vesicles, however, appear reasonably well preserved. These 
structural changes apparently occur after fixation, during 
resin polymerization. In surface-labeled specimens (L. R. 
White-embedded and thin frozen), the precision of antigen 
localization on sections can be expected to vary from 0 to 
~27 nm (size of two antibody molecules plus the size of the 
gold particle). 
The anti-BSA antibody was shown by ELISA to bind at 
low affinity to (endogenous) murine serum albumin. There- 
fore, to reduce background and exclude erroneous localiza- 
tions of our tracer, BSA, we performed preliminary tests 
which established that a 10-min flush with a protein-free per- 
fusate was sufficient to remove almost all of the detectable 
murine albumin from the vascular lumina, endothelium, and 
pericapillary spaces (Fig. 3 A). The result was a very low 
background labeling against which the perfused exogenous 
BSA could be unequivocally identified. 
After BSA perfusion for >1 min, the tracer was detected 
on the luminal surface of the endothelium, in plasmalemmal 
vesicles,  and in the pericapillary spaces,  but the amount 
present in the latter was too high to allow a reliable identifica- 
tion of  the structures involved in albumin transport across the 
endothelium. These experiments showed that monomeric 
BSA was much more rapidly transported than AuBSA, and 
prompted us to reduce stepwise the perfusion time of the 
tracer. Before that, however,  we tested the effect of a  l-rain 
PBSG flush introduc~ in the protocol after the tracer. The 
flush removed the BSA from the lumina and practically all 
plasmalemmal vesicles open on the luminal front of the en- 
dothelium (Fig. 3 B). BSA was still detected in plasmalem- 
mal vesicles on the abluminal front and was present in the 
pericapillary spaces again in quantifies large enough to pre- 
clude an accurate identification of the structures involved in 
its transport. These findings indicate that monomeric BSA 
binds to the endothelial surface (plasmalemmal vesicles in- 
cluded) with considerably lower affmity than AuBSA, which, 
as already mentioned, can be considered as a  polymeric 
equivalent of BSA. When the 1 min PBSG prefixation flush 
was omitted, albumin was detected on the luminal surface of 
the endothelium, in plasmalemmal vesicles throughout the 
endothelial layer, and in the pericapillary spaces. In the latter 
location, however,  there was an apparent decrease in tracer 
concentration (Fig. 3 C) probably reflecting a reduction by 
~1 rain in time available for albumin transport, in addition 
to the partial flushing of these spaces. 
When the perfusion time was reduced to 30 s and the post- 
perfusion flush was omitted, we were able to localize albu- 
min on the luminal aspect of the plasmalemma, in vesicles 
on both the luminal and abluminal front of the endothelium 
and in all pericapillary spaces (Fig. 4 A). Albumin in vesicles 
on the abluminal front of the endothelium was generally at 
a  higher concentration than in the adjacent extravascular 
space. No albumin was detected in the intercellular  junctions, 
nor was a  concentration of tracer seen in the intercellular 
spaces abluminal to the  junctions and no tracer"clouds" were 
found in the pericapillary spaces centered on exits from en- 
dothelial intercellular spaces. 
After further reduction in the BSA perfusion time to 15 s, 
the distribution of albumin was similar to that found at 30 s 
(Fig.  4  B)  except that the  amount of albumin in  transit 
through the endothelium or already arrived in the pericapil- 
lary spaces appeared to be smaller. 
Thin Sections of Frozen Specimens. V(~th recently im- 
proved embedding and ultramicrotomy procedures,  struc- 
tural preservation of microvessels is considerably better in 
thin sections of frozen tissue than in L. R. White-processed 
specimens. In controls, labeling due to nonspecific binding 
or to residual endogenous murine albumin was very low 
(Fig. 5 A), yet higher than in corresponding L. R. White- 
embedded preparations, presumably because frozen sections 
are thicker. 
In the capillaries of specimens processed after a l-rain per- 
fusion with BSA (without a subsequent flush with PBSG), 
there was heavy labeling of the luminal aspect of the en- 
dothelial plasmalemma, extensive labeling of the plasma- 
lemmal vesicles irrespective  of their position within the 
endothelium, and minimal labeling of the intercellular junc- 
tions. There was also especially heavy and apparently ran- 
domly distributed labeling of the pericapillary spaces and on 
these accounts it was not possible to identify the structures 
involved in the transport of the tracer (Fig. 5 B). 
When the perfusion time was reduced to 30 s (Fig. 6 A), 
less BSA was detected in the pericapillary spaces. In addi- 
tion, the highest local concentrations of tracer were not as- 
sociated with the abluminal end of the intercellular spaces 
but with segments of attenuated endothelium rich in plas- 
malemmal vesicles. Gold particles were observed on the lu- 
minal and abluminal aspect of endothelial cell junctions. 
However, labeling was not detected throughout the length of 
a junction, nor was a gradient of labeling detected in the ex- 
travascular space (Fig. 6 B) with a peak centered on the ablu- 
minal exit of any intercellular space. 
After a further reduction in perfusion time to 15 s, the dis- 
tribution of the tracer within the endothelium was compa- 
rable with that found at 30 s, but the labeling of the sub- 
endothelial spaces  was clearly reduced and preferentially 
concentrated near open (apparently discharging) plasmalem- 
mal vesicles on the abluminal front (Fig. 6 C). Intercellular 
junctions and exits from intercellular spaces were minimally 
labeled and gradients centered on  junctions were not present. 
All specimens were processed without a post-BSA flush, 
and at all time points examined, labeling of the luminal as- 
pect of the plasmalemma was quite extensive and apparently 
randomly scattered. It was definitely not preferentially re- 
stricted to plasmalemmal vesicles and "dimples" open on the 
luminal front as in the case of AuBSA complexes in our ex- 
periments and in those of Ghitescu et al. (8). We assume that 
without a postperfusion flush, we detect BSA in both plas- 
malemmal vesicles and the fiber matrix that appears to cover 
the entire luminal surface of the endothelium. 
Milir  et al. Endothelial Transport of  Albumin  2607 Figure 4. Immunogold localization of monomeric albumin in the endothelium and pericapillary  spaces of myocardial capillaries in L. R. 
White-embedded specimens. (A) This micrograph demonstrates the general pattern of gold anti-albumin  labeling after 30 s of albumin 
perfusion without a subsequent PBSG flush. Labeled vesicles are pointed out on both the luminal (long arrows) and abluminal (short arrows) 
front of the endothelium.  Bar, 0.2 I~m. (B) In this micrograph,  the same pattern of labeling as in A is seen after only  15 s of albumin 
perfusion.  Bar, 0.2 ~tm. 
Morphometry 
At all time points examined, BSA was detected in only a frac- 
tion (,,o16%, 8--45 % range) of the total plasmalemmal vesicle 
population. Whereas this percentage ranged in different ran- 
dom micrographs, there was no difference observed in the 
percentage of labeled vesicles from 15 s to 1 min perfusion 
with BSA. The background labeling of vesicles in the con- 
trois was observed to be ,,03%  (0-7%  range). 
We measured 0.5 t~m  2 of sectioned extravascular space in 
association with endothelial cell junctions  and  1.1  0ra  2 in 
areas away from the junctions and counted therein 82 and 
234 gold particles, respectively. For easier comparison, we 
normalized the figures to  1  I~m  2 and  in this  case detected 
164 gold particles in association with junctions and 212 gold 
particles in areas away from the junctions. 
Discussion 
Experimental Protocols 
Albumin was chosen as the tracer for these experiments be- 
cause of its physiological relevance and because its transport 
from the blood plasma to the interstitial fluid and to lymph 
is expected to occur at a higher rate in the myocardium than 
The Journal of Cell Biology, Volume 105, 1987  2608 Figure 5. Immunogold  localization of  albumin in the endothelium and adjacent interstitium  of  myocardial  capillaries in thin frozen sections. 
(A) This micrograph shows  a control demonstrating  the low background labeling (arrowheads) of  the endothelium and pericapillary spaces. 
Bar, 0.2 gin. (B) Specimen perfused with albumin for 1 rain. Labeled vesicles on the luminal (long arrows) and abluminal (short arrows) 
surface are pointed out. Bar, 0.2 am. 
in most other organs. Albumin represents ,x,74  % of the total 
proteins of cardiac lymph, and the ratio plasma protein/ 
cardiac lymph protein is 0.6 (7).  For logistics reasons, we 
used an exogenous albumin (bovine) as a tracer instead of  the 
endogenous (murine) albumin, hence the necessity of re- 
moving endogenous albumin from vascular lumina, capil- 
lary wails, and interstitia by appropriate flushing with pro- 
tein-free PBSG. 
BSA was administered as a bolus at the nearly physiologi- 
cal concentration of 30 mg/ml with the intent of obtaining a 
high signal and of minimizing the effects of low protein con- 
centration in the perfusate. Old (13) as well as recent (14) data 
indicate that capillary permeability increases at a  protein 
concentration <0.01% but is restored promptly ("~30 s) to al- 
ready normal levels when the concentration is increased to 
1% (11). In our experiments an increase in capillary perme- 
ability may apply at the very beginning of BSA perfusions, 
but it is expected to be transient and not to involve other than 
normal exit pathways. 
AuBSA Complexes 
We found that AuBSA complexes bind extensively and pref- 
erentially to plasmalemmal vesicles open on the luminal 
front of  the endotheliurn, and to shallow depressions or dim- 
pies which may represent early stages in vesicle formation. 
They also bind to a more limited extent to the plasmalemma 
proper.  In  addition,  AuBSA complexes were  detected in 
small  numbers  in  vesicles  scattered  throughout  the  en- 
dothelium,  and in  vesicles  discharging on the  abluminal 
front, but the latter were seen only occasionally after rela- 
tively long perfusion times: >10 min in our experiments; ,v5 
min, in those of Ghitescu et al. (8). AuBSA complexes were 
also detected in larger vesicles of irregular profiles tenta- 
Milici et al. Endothelial  Transport of Albumin  2609 Figure 6. Immunogold  localization  of albumin  in the endothelium  and adjacent interstitium  of myocardial capillaries in thin frozen sections. 
(A) After 30 s of albumin perfusion, labeled vesicles are found on both the luminal (long arrow)  and abluminal (short arrow) front of 
the endothelium. No tracer is detected in the intercellular  junction (J) and the subjacent intercellular space. Albumin is detected in the 
pericapillary spaces, but the concentration of gold anti-albumin  in the sector immediately under the intercellular  junction (arrowheads) 
is lower than in the rest of these spaces. Bar, 0.2 ~tm. (B) Micrograph  of another section from the specimen in A. It shows an endothelial 
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labeling of the plasmalemmal vesicle membranes, our find- 
ings with AuBSA confirm those with AuBSA documented by 
Ghitescu et al. (8) for rat pulmonary capillaries. The results 
of our washing experiments indicate, however,  that mono- 
merit albumin binds with considerably less affinity than 
polymeric albumin (AuBSA)  to the membrane of plasma- 
lemmal vesicles. 
The two-step experiments (first AuBSA perfusion and then 
reaction of vibratome sections with HRP-conjugated anti- 
BSA) expanded our findings by demonstrating that albumin 
forms around each gold particle a  continuous, relatively 
thick coat that is retained during transport across the en- 
dothelium. AuBSA complexes found in endosomes and in 
many (but not all) plasmalemmal vesicles within the en- 
dothelial cytoplasmic matrix were not stained by the anti- 
body, which is taken to mean that during specimen incu- 
bation  the  vesicles  and  vacuoles  were  not accessible  to 
HRP-anti-BSA conjugates.  The apparent diameter of the 
AuBSA complexes, revealed by the peroxidatic reaction, was 
found to average 14.5 nm, which would indicate that they can 
be used as exclusive probes for the postulated large-pore sys- 
tem (diam, >10 nm) of the capillary walls. 
Monomeric Albumin 
The most important findings, made possible by the use of 
monomeric albumin as tracer, can be listed as (a) extensive 
labeling of the luminal plasmalemma, (b) labeling of a frac- 
tion of the total population of plasmalemmal vesicles, (c) 
rapid (<15 s) and substantial transport of the tracer to the 
pericapillary spaces,  (d) restriction of the tracer to plas- 
malemmal vesicles while in transit across the endothelium, 
(e) absence of detectable albumin gradients associated with 
intercellular junctions, and (f) rapid removal of the label by 
short PBSG flushes (1 min), hence apparently low-affinity  al- 
bumin  binding  to  the  endothelium  and  associated  plas- 
malemmal vesicles. The transport time, given as the interval 
between the start of tracer perfusion and the start of fixative 
perfusion,  is  an underestimate, because previous  experi- 
ments (1) have established that ,'-,6-9 s of fixative perfusion 
are required to reduce drastically the appearance of tracer- 
loaded vesicles on the abluminal front of the endothelium (the 
tracer used in those experiments was HRP). We assume that 
20-25 s is probably not sufficient to fully dissipate gradients 
centered on the exits from intercellular spaces and that inter- 
cellular junctions are not preferentially flushed by the fixa- 
tive. (We have shown that the latter does not flush the tracer 
from the luminal plasmalemma and plasmalemmal vesicles). 
Monomeric vs. Polymeric Albumin 
In addition to obvious differences in the rate of transport and 
amount of transported tracer, there are other differences be- 
tween the behavior of monomeric and polymeric albumin 
(AuBSA complexes) that deserve comment. The easy re- 
moval of monomeric albumin by relatively snort flushes with 
PBSG suggests that the binding of albumin on the luminal 
surface and in plasmalemmal vesicles has a low association- 
dissociation constant.  In contrast,  the tenaciously bound 
AuBSA complexes cannot be displaced from the membrane 
of plasmalemmal vesicles by extensive flushing but the bind- 
ing is competable with monomeric albumin (8). The multi- 
functional character of  AuBSA is probably the reason for the 
diversion of part of the tracer to endosomes and it may also 
explain the slow rate of transport. 
Relations to Postulated Pores 
Smallpores. The results obtained with monomeric albumin 
suggest that the structural equivalents of the small pores are 
the plasmalemmal vesicles as far as macromolecular solutes 
are concerned. They probably function as transcytotic vesic- 
ular carriers, thereby accounting for the dissipative compo- 
nent of the plasma-interstitial fluid macromolecular etflux 
(21, 22); they may also form transient transendothelial chan- 
nels that could account for part of the convective component 
of the exchanges. In addition, the results now obtained with 
monomeric albumin validate earlier findings coming from 
work done with either albumin (23, 30) or a series of  proteins 
with peroxidatic activity ranging in mass from 1.8 to 50 kD 
(123, 25, 26). In these cases, however, it was difficult to ob- 
tain generally accepted evidence because specimen fixation 
was slow (and tracers had time to diffuse), and because a de- 
tection procedure of low resolution (the diaminobenzidine- 
H202-peroxidase  reaction) was used. 
Large pores.  The results we obtained with AuBSA com- 
plexes suggest that plasmalemmal vesicles also function as 
large pore equivalents, because they transport particles that 
dimensionwise (;~10 nm) qualify for exclusive large pore 
probes. Vesicles functioning as large pore equivalents may 
also  form transendothelial channels,  thereby providing a 
convective component to the transport of large (diam, >t10 
nm) particles. These interpretations, although clearly sup- 
ported by our evidence, are still in need of confirmation by 
other laboratories using the same or similar tracers. 
Further work is needed to find out whether the two pore 
functions are subserved by different populations or the same 
population of plasmalemmal vesicles and, in the second al- 
ternative, what mechanisms explain the ability of certain 
vesicles to take up and transport large particles. Although 
our findings strongly favor albumin transport via vesicles, 
they cannot provide an unambiguous answer as to the de- 
tailed mechanisms involved. The vesicles may function as 
shuttles from one front of the endothelium to the other (3, 
18, 19) or may work as relays from one front to vesicles al- 
3. Vesicles  were labeled  but the author  concluded  that  the tracer  left  the lu- 
mina through  the junctions. 
intercellular junction (Jr) covered by a pericyte (P) and demonstrates that the concentration of tracer is considerably lower in the narrow 
space between the endothelium and the pericyte than in the rest of the pericapiUary spaces. The narrow space would favor  the maintenance 
of  a tracer gradient if  albumin would exit through the intercellular  junction. Bar, 0.2 B  m. (C) There is detectable  albumin in the extravascular 
space in association with plasmalemmal vesicles (short arrow) after only 15 s of albumin perfusion. There is also extensive labeling of 
the plasmalemma proper (arrowheads). The introit to an intercellular junction (J) is labeled but the junction itself is free of tracer. Bar, 
0.2 Ixm. 
Milici et al. Endothelial Transport of Albumin  2611 ready open at the other front as proposed by Clough and 
Michel (4) for frog mesenteric capillaries or they may estab- 
lish transient transendothelial  channels  (25).  Further work 
is needed to provide an answer to this question in mammalian 
myocardial  capillaries.  Additional  work is also needed to 
define, in molecular terms, the interactions of albumin with 
both the plasmalemma proper  and with the membrane  of 
plasmalemmal vesicles.  Work along these lines is already 
proceeding (24). 
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